Income statement
USD
Annual
| Metric | 2022 | 2021 | 2020 | 2011 | 2010 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -110K | -59K | -59K | -969K | -272K |
| EBITDA | 108K | -59K | -59K | -960K | -960K |
| Net Income | -129K | -59K | -59K | -969K | -271K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sentry Petroleum Ltd (SPLM) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -120.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -120.0%, free cash flow -3982.9% with operating margin 0.0% and ROIC 42.4%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SPLM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SPLM
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SPLM Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SPLM and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$271.0K
+72.0% YoY
Free Cash Flow
-$215.5K
+11.3% YoY
Revenue Growth
+0.0%
EPS Growth
-120.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2011 | 2010 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -110K | -59K | -59K | -969K | -272K |
| EBITDA | 108K | -59K | -59K | -960K | -960K |
| Net Income | -129K | -59K | -59K | -969K | -271K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2020 | 2011 | 2010 |
|---|---|---|---|---|---|
| Cash & Equivalents | 0 | 0 | 0 | 687K | 318K |
| Total Assets | 0 | 0 | 0 | 1M | 673K |
| Total Liabilities | 416K | 306K | 50K | 103K | 62K |
| Shareholder Equity | -416K | -306K | -50K | 1M | 610K |
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Net Debt | 0 | 0 | 0 | -687K | -318K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
20K
+111.5% YoY
Capital Expenditures
236K
-260.4% YoY
Free Cash Flow
216K
+11.3% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
35.7%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.